Why Market Size Forecasters?
- Reports at Lowest Prices - Guaranteed
- Fastest Growing Research Reports’ Database
- Easy Customization Options
- 24 X 7 Support Commitment
- Certified, Safe & Secured Payments
About Clinical Trial Management System (CTMS) Clinical trials are defined as research studies undertaken to successfully test a drug or a medical device before launching the product in the market. These studies are pivotal as the data generated in these studies forms the basis for the approval process of a drug or a medical device. Typically, these clinical trials are divided into five phases with each phase as critical as any other. It takes approximately 12 years to successfully complete a clinical trial, and the typical cost estimate of a clinical trial is $800 million to $1.2 billion with a success rate of 12% that the drug will get approved in the market or not. Technavio?s analysts forecast the global clinical trial management system (CTMS) market to grow at a CAGR of 12.98% during the period 2017-2021 . Covered in this report The report covers the present scenario and the growth prospects of the global clinical trial management system (CTMS) market for 2017-2021 . To calculate the market size, the report considers the revenue generated from the retail sales of CTMS components that comprise software and services. The market is divided into the following segments based on geography: ? Americas ? APAC ? EMEA Technavio's report, Global Clinical Trial Management System (CTMS) Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors ? Bioclinica ? Medidata ? Oracle ? PAREXEL Other prominent vendors ? ArisGlobal ? Bio-Optronics ? DATATRAK ? DSG ? ERT Clinical ? FORTE ? MedNet Solutions ? Merge ? Trial By Fire Solutions ? Veeva Systems Market driver ? Increase in R&D expenditure ? For a full, detailed list, view our report Market challenge ? Rising cost of clinical trials ? For a full, detailed list, view our report Market trend ? Increasing outsourcing of clinical trial process ? For a full, detailed list, view our report Key questions answered in this report ? What will the market size be in 2021 and what will the growth rate be? ? What are the key market trends? ? What is driving this market? ? What are the challenges to market growth? ? Who are the key vendors in this market space? You can request one free hour of our analyst?s time when you purchase this market report. Details are provided within the report.
Table of Contents PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: INTRODUCTION ? Market outline PART 05: MARKET LANDSCAPE ? Market size and forecast ? Five forces analysis PART 06: MARKET SEGMENTATION BY END-USERS ? Global CTMS market by end-users ? Global CTMS market by pharmaceutical and biotechnology companies ? Global CTMS market by CROs ? Global CTMS market by others PART 07: REGIONAL LANDSCAPE ? Geographical segmentation ? Regional comparison ? Americas ? Market size and forecast ? EMEA ? Market size and forecast ? APAC ? Market size and forecast ? Key leading countries ? Market opportunity PART 08: DECISION FRAMEWORK PART 09: DRIVERS AND CHALLENGES ? Market drivers ? Market challenges PART 10: MARKET TRENDS ? Increasing outsourcing of clinical trial process ? Integration of CTMS with other systems ? Adoption of cloud computing PART 11: VENDOR LANDSCAPE ? Competitive scenario ? Investment opportunity PART 12: KEY VENDOR ANALYSIS ? Bioclinica ? Medidata ? Oracle ? PAREXEL ? Other prominent vendors PART 13: APPENDIX ? List of abbreviations List of Exhibits? Exhibit 01: Various phases in a clinical trial Exhibit 02: Advantage of CTMS Exhibit 03: Global CTMS market: Market overview Exhibit 04: Global CTMS market 2016-2021 ($ millions) Exhibit 05: Factors impacting the global CTMS market Exhibit 06: Five forces analysis Exhibit 07: Global CTMS market by end-users 2016-2021 (% share) Exhibit 08: Global CTMS market by end-users: Snapshot Exhibit 09: Global CTMS market by pharmaceutical and biotechnology companies 2016-2021 ($ millions) Exhibit 10: Global CTMS market by CROs 2016-2021 ($ millions) Exhibit 11: Advantage of using CTMS in retrieving data from CROs Exhibit 12: Leading CROs with internally developed CTMS systems Exhibit 13: Global CTMS market by others 2016-2021 ($ millions) Exhibit 14: Global CTMS market by geography 2016-2021 (% share) Exhibit 15: Regional comparison Exhibit 16: Americas ? Market size and forecast 2016-2021 ($ millions) Exhibit 17: Americas ? Year-over-year growth Exhibit 18: EMEA ? Market size and forecast 2016-2021 ($ millions) Exhibit 19: EMEA ? Year-over-year growth Exhibit 20: APAC ? Market size and forecast 2016-2021 ($ millions) Exhibit 21: APAC ? Year-over-year growth Exhibit 22: Key leading countries Exhibit 23: Strategic success factors for vendors Exhibit 24: Investment opportunity mapping Exhibit 25: Bioclinica: Profile Exhibit 26: Bioclinica: Strength analysis Exhibit 27: Bioclinica: Strategy assessment Exhibit 28: Bioclinica: Opportunity assessment Exhibit 29: Medidata: Profile Exhibit 30: Medidata: Strength analysis Exhibit 31: Medidata strategy assessment Exhibit 32: Medidata: Opportunity assessment Exhibit 33: Oracle: Profile Exhibit 34: Oracle: Strength analysis Exhibit 35: Oracle: Strategy assessment Exhibit 36: Oracle: Opportunity assessment Exhibit 37: PAREXEL: Profile Exhibit 38: PAREXEL: Strength analysis Exhibit 39: PAREXEL: Strategy assessment Exhibit 40: PAREXEL: Opportunity assessment
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Primary research - Manufacturers/Suppliers, Channel partners, Industry experts, Strategic decision makers
Secondary research - Technavio internal repository, Industry journals and periodicals, Government bodies, Annual reports of key stakeholders
Data synthesis - Collation of data, Estimation of key figure, Analysis of derived insights
Data validation - Triangulation with data models, Reference against proprietary databases, Corroboration with industry experts
Qualitative analysis - Market drivers, Market challenges, Market trends, Five forces analysis
Quantitative analysis- Market size and forecast, Market segmentation, Geographical insights, Competitive landscape
Technavio’s database and industry-specific repositories are used for defining the hypothesis for the study, which is further fine-tuned through primary research involving industry experts. The success of our approach lies in the fact that we take the viewpoint of all stakeholders into consideration while analyzing an industry, and objectively assess each outlook.
Why Market Size Forecasters?